According to the present study , CoQ10 , when given at a dose of 200 mg/d for 12 weeks to a group of neuropathic diabetic patients , did not improve the neuropathy signs compared to placebo , although it had some beneficial effects on TAC and hsCRP and probably a protective effect on insulin resistance .